Literature DB >> 21717877

Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand.

Paiboon Jivapaisarnpong1, Kanya Boonthongtho.   

Abstract

BACKGROUND: The clinicopathological characteristics of colorectal mucinous adenocarcinoma (MA) are still controversial. Most of the reports suggested that MA were associated with worse clinicopathological behavior and poorer prognosis than non-mucinous adenocarcinoma (NMA) while the others showed no difference.
OBJECTIVE: To compare clinicopathological characteristics and tumor recurrence of MA patients with those in NMA patients. MATERIAL AND
METHOD: During the period of 2000 to 2009 in Rajavithi Hospital, a total of 427 colorectal adenocarcinoma patient records consisting of 407 NMA and 20 MA were included in this study. Mean age, tumor location, TNM staging at diagnosis, T-stage, N-stage, preoperative CEA level and recurrent rate of MA patients were compared with those of NMA patients.
RESULTS: The distribution of MA patients for gender, mean age, tumor location, TNM stage and preoperative CEA level were similar to those of NMA patients (all p > 0.05). Only the tumor recurrence in MA was significantly more common than that in NMA (p = 0.020, OR = 3.28 (1.14-9.43)), whereas the TNM stage was not significantly different from NMA (p = 0.530). The metastatic site and pattern of metastasis also showed no statistical significance (p = 0.125).
CONCLUSION: The prognosis of MA is poorer than NMA. This may be associated with mucinous histological type itself.

Entities:  

Mesh:

Year:  2011        PMID: 21717877

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Overall survival is improved in mucinous adenocarcinoma of the colon.

Authors:  J Hogan; J P Burke; G Samaha; E Condon; D Waldron; P Faul; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2014-01-15       Impact factor: 2.571

2.  Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.

Authors:  Yuan-Tzu Lan; Shih-Ching Chang; Pei-Ching Lin; Chun-Chi Lin; Hung-Hsin Lin; Shen-Chieh Huang; Chien-Hsing Lin; Wen-Yi Liang; Wei-Shone Chen; Jeng-Kai Jiang; Jen-Kou Lin; Shung-Haur Yang
Journal:  Front Oncol       Date:  2021-03-02       Impact factor: 6.244

3.  The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma.

Authors:  Dehao Yu; Peng Gao; Yongxi Song; Yuchong Yang; Xiaowan Chen; Yu Sun; Ailin Li; Zhenning Wang
Journal:  Cancer Med       Date:  2018-01-29       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.